NORTHERN TRUST CORP - MILLENDO THERAPEUTICS INC ownership

MILLENDO THERAPEUTICS INC's ticker is MLND and the CUSIP is 60040X103. A total of 58 filers reported holding MILLENDO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of MILLENDO THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$38,000
-49.3%
31,690
-9.9%
0.00%
Q4 2020$75,000
+11.9%
35,165
-14.6%
0.00%
Q3 2020$67,000
+8.1%
41,155
+17.0%
0.00%
Q2 2020$62,000
-92.4%
35,173
-77.3%
0.00%
Q1 2020$817,000
+3.9%
154,731
+32.7%
0.00%
Q4 2019$786,000
-1.4%
116,614
+4.0%
0.00%
Q3 2019$797,000
+67.1%
112,120
+171.5%
0.00%
Q2 2019$477,00041,2890.00%
Other shareholders
MILLENDO THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 1,396,615$9,930,0003.10%
NEA Management Company, LLC 1,766,779$12,562,0001.04%
Samsara BioCapital, LLC 186,540$1,326,0000.90%
GREAT POINT PARTNERS LLC 1,288,093$9,158,0000.84%
Bpifrance SA 1,078,670$7,669,0000.83%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 177,825$1,264,0000.58%
ADAMS STREET PARTNERS LLC 367,935$2,616,0000.52%
Prosight Management, LP 52,051$370,0000.20%
GMT CAPITAL CORP 53,419$380,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 38,881$276,0000.00%
View complete list of MILLENDO THERAPEUTICS INC shareholders